NASDAQ
No price data available for this timeframe.
Aktis Oncology, Inc. (AKTS) has a fcf yield of -6.27% as of Tuesday, August 4, 2026. This represents a 247.02% decrease compared to its 12-month average of -1.81%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.